Exagen Inc (XGN) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue, 14th Straight ASP Gain, ...
Exagen Inc (XGN) posted its best-ever third quarter with $18.4 million in revenue, record $451 ASP, and 85% Pharma Services growth, while teeing up its highly anticipated myositis test for early 2027. Related Stocks: XGN ,